4//SEC Filing
Harris Matthew Scott 4
Accession 0001104659-24-010779
CIK 0001326190other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:01 PM ET
Size
14.7 KB
Accession
0001104659-24-010779
Insider Transaction Report
Form 4
Harris Matthew Scott
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-02-01−6,166→ 6,166 total→ Common Stock, par value $0.0001 (6,166 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-02−7,775→ 15,550 total→ Common Stock, par value $0.0001 (7,775 underlying) - Tax Payment
Common Stock, par value $0.0001
2024-02-02$9.32/sh−2,332$21,734→ 53,633 total - Exercise/Conversion
Common Stock, par value $0.0001
2024-02-01+6,166→ 49,991 total - Exercise/Conversion
Common Stock, par value $0.0001
2024-02-02+7,775→ 55,965 total - Tax Payment
Common Stock, par value $0.0001
2024-02-01$9.88/sh−1,801$17,794→ 48,190 total
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- [F3]The RSUs become vested in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
- [F4]The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001787762
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 6:01 PM ET
- Size
- 14.7 KB